Plasma-Lyte 56 and Dextrose and Ustekinumab Subcutaneous
Determining the interaction of Plasma-Lyte 56 and Dextrose and Ustekinumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lvp solution with potassium
Brand name:
Synonyms: Dextrose and Electrolyte No 48
Generic Name: ustekinumab
Brand name: Stelara, Stelara PFS
Synonyms: Ustekinumab (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Plasma-Lyte 56 and Dextrose-Ustekinumab Subcutaneous Injection
- Plasma-Lyte 56 and Dextrose-Ustell
- Plasma-Lyte 56 and Dextrose-UTA
- Plasma-Lyte 56 and Dextrose-UTA Capsules
- Plasma-Lyte 56 and Dextrose-UTAC tablets
- Plasma-Lyte 56 and Dextrose-UTI Relief
- Ustekinumab Subcutaneous-Platinol
- Ustekinumab Subcutaneous-Platinol-AQ
- Ustekinumab Subcutaneous-Plavix
- Ustekinumab Subcutaneous-Plazomicin
- Ustekinumab Subcutaneous-Plazomicin Intravenous
- Ustekinumab Subcutaneous-Plazomicin Sulfate